ArticleMicrosystems & nanoengineering2025

Single-Cell-Derived Tumor Organoid (STO) arrays on a microfluidic chip for personalized drug screening to address heterogeneity-induced drug resistance in colorectal cancer.

Dongguo Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.